Q4 2018 Holdings
Filed 2019-02-14 | 23 holdings | $12.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bausch Health Cos Inc(BHC) | COM | 071734107 | $12.3M | 664,837 | 98.2% |
| Spdr S&P Biotech ETF(XBI)Put | S&P BIOTECH | 78464A870 | $35.8K | 499,200 | 0.3% |
| BioMarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $29.1K | 341,400 | 0.2% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $27.1K | 316,117 | 0.2% |
| Teva Pharmaceutical Industries(TEVA)Call | SPONSORED ADR | 881624209 | $26.0K | 1,683,500 | 0.2% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $21.2K | 819,164 | 0.2% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $16.3K | 764,193 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $12.8K | 894,679 | 0.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $11.0K | 838,946 | 0.1% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $9.1K | 221,662 | 0.1% |
| Horizon Pharma Plc | SHS | G4617B105 | $7.7K | 396,198 | 0.1% |
| Stemline Therapeutics Inc | COM | 85858C107 | $6.8K | 711,558 | 0.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $6.1K | 307,739 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $5.6K | 714,764 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $3.3K | 1,066,439 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $3.0K | 376,010 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $2.6K | 121,892 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $2.3K | 249,496 | 0.0% |
| Zosano Pharma Corp | COM NEW | 98979H202 | $1.7K | 798,719 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $1.6K | 123,305 | 0.0% |
| Osmotica Pharmaceuticals PLC | SHS | G6S41R101 | $935 | 120,620 | 0.0% |
| MediWound Ltd | ORD SHS | M68830104 | $424 | 104,546 | 0.0% |
| Vaccinex Inc | COM | 918640103 | $62 | 17,047 | 0.0% |